Department of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, Hungary.
Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Br J Pharmacol. 2019 Feb;176(4):646-670. doi: 10.1111/bph.14394. Epub 2018 Aug 23.
BACKGROUND AND PURPOSE: Posttranslational modifications of cysteine residues represent a major aspect of redox biology, and their reliable detection is key in providing mechanistic insights. The metastable character of these modifications and cell lysis-induced artifactual oxidation render current state-of-the-art protocols to rely on alkylation-based stabilization of labile cysteine derivatives before cell/tissue rupture. An untested assumption in these procedures is that for all cysteine derivatives, alkylation rates are faster than their dynamic interchange. However, when the interconversion of cysteine derivatives is not rate limiting, electrophilic labelling is under Curtin-Hammett control; hence, the final alkylated mixture may not represent the speciation that prevailed before alkylation.
Buffered aqueous solutions of inorganic, organic, cysteine, GSH and GAPDH polysulfide species were used. Additional experiments in human plasma and serum revealed that monobromobimane can extract sulfide from the endogenous sulfur pool by shifting speciation equilibria, suggesting caution should be exercised when interpreting experimental results using this tool.
In the majority of cases, the speciation of alkylated polysulfide/thiol derivatives depended on the experimental conditions. Alkylation perturbed sulfur speciation in both a concentration- and time-dependent manner and strong alkylating agents cleaved polysulfur chains. Moreover, the labelling of sulfenic acids with dimedone also affected cysteine speciation, suggesting that part of the endogenous pool of products previously believed to represent sulfenic acid species may represent polysulfides.
We highlight methodological caveats potentially arising from these pitfalls and conclude that current derivatization strategies often fail to adequately capture physiological speciation of sulfur species.
This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
背景和目的:半胱氨酸残基的翻译后修饰代表了氧化还原生物学的一个主要方面,其可靠检测是提供机制见解的关键。这些修饰的亚稳特性和细胞裂解引起的人为氧化使得当前最先进的协议依赖于在细胞/组织破裂之前基于烷基化稳定不稳定的半胱氨酸衍生物。在这些程序中未经过测试的假设是,对于所有半胱氨酸衍生物,烷基化速率都快于它们的动态交换。然而,当半胱氨酸衍生物的相互转化不是限速步骤时,亲电标记受 Curtin-Hammett 控制;因此,最终的烷基化混合物可能不代表烷基化之前占主导地位的形态。
使用无机、有机、半胱氨酸、GSH 和 GAPDH 多硫化物的缓冲水溶液。在人血浆和血清中的额外实验表明,单溴代丁二酰亚胺可以通过改变形态平衡从内源硫池中提取硫化物,这表明在使用此工具解释实验结果时应谨慎行事。
在大多数情况下,烷基化多硫化物/巯基衍生物的形态取决于实验条件。烷基化以浓度和时间依赖的方式干扰硫形态,强烷基化剂会切断多硫链。此外,二甲基酮对亚磺酸的标记也会影响半胱氨酸的形态,这表明部分以前被认为代表亚磺酸的内源性产物池可能代表多硫化物。
我们强调了这些陷阱可能带来的方法学注意事项,并得出结论,当前的衍生化策略往往不能充分捕获硫物种的生理形态。
本文是关于活性硫物种的化学生物学的专题部分的一部分。要查看本节中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.